SONOS, INC. financials

SONO CIK 0001314727

Source: EDGAR filings · Built 2026-06-02T04:04:48Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 108.19M 134.66M 50.12M -74.48M 207.69M 128.95M
EBITDA 11.85M 4.33M 28.42M 128.04M 188.85M 9.19M
Working Capital 151.62M 184.93M 305.41M 331.75M 481.38M 267.36M
Net Debt -115.05M -105.60M -164.12M -238.73M -595.42M -320.91M
Gross Margin 43.69% 45.41% 43.29% 45.45% 47.18% 43.12%
Operating Margin -3.50% -3.17% -1.24% 5.11% 9.03% -2.05%
Net Margin -4.24% -2.51% -0.62% 3.85% 9.24% -1.52%
Return on Equity (ROE) -17.21% -8.90% -1.98% 12.02% 27.87% -6.75%
Return on Assets (ROA) -7.43% -4.16% -1.03% 5.67% 13.93% -2.46%
Current Ratio 1.43× 1.51× 1.86× 1.62× 2.01× 1.68×
Debt-to-Equity 0.17× 0.15× 0.11× 0.06× 0.08× 0.29×
Effective Tax Rate -21.08% -40.50% 333.82% 1.96% -1.06% -0.16%
Cash Conversion Ratio -2.24× -4.98× -9.77× -0.42× 1.60× -8.05×
Accruals Ratio -0.24× -0.25× -0.11× 0.08× -0.08× -0.22×
SBC % of Revenue 5.65% 5.55% 4.64% 4.32% 3.62% 4.34%
CapEx Coverage 4.77× 3.44× 2.00× -0.61× 5.56× 4.90×
Free Cash Flow Per Share $0.90 $1.09 $0.39 $-0.54 $1.48 $1.17

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 28.37× 28.55×
P/FCF 17.08× 11.12× 32.89× 21.79× 13.20×
FCF Yield 5.86% 8.99% 3.04% 4.59% 7.58%
EV / EBITDA 145.31× 317.14× 51.06× 11.89× 18.54× 154.51×
P/S 1.27× 0.97× 0.98× 1.00× 2.39× 1.31×
P/B 5.17× 3.45× 3.11× 3.14× 7.20× 5.85×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 1.44B 1.52B 1.66B 1.75B 1.72B 1.33B
Cost of Goods and Services Sold 812.75M 828.68M 938.76M 955.97M 906.75M 754.37M
Gross Profit 630.53M 689.37M 716.49M 796.37M 809.99M 571.96M
Research and Development Expense 279.97M 304.56M 301.00M 256.07M 230.08M 214.67M
Operating Expenses 681.00M 737.42M 737.04M 706.84M 655.03M 599.19M
Operating Income (Loss) -50.47M -48.05M -20.55M 89.53M 154.96M -27.23M
Income Tax Expense (Benefit) 10.65M 10.99M 14.67M 1.35M -1.67M 32.00K
Net Income (Loss) Attributable to Parent -61.14M -38.15M -10.27M 67.38M 158.59M -20.11M
Earnings Per Share, Basic $-0.51 $-0.31 $-0.08 $0.53 $1.30 $-0.18
Weighted Average Number of Shares Outstanding, Basic 120.75M 123.22M 127.70M 127.69M 122.25M 109.81M
Earnings Per Share, Diluted $-0.51 $-0.31 $-0.08 $0.49 $1.13 $-0.18
Weighted Average Number of Shares Outstanding, Diluted 120.75M 123.22M 127.70M 137.76M 140.31M 109.81M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 174.67M 169.73M 220.23M 274.86M 640.10M 407.10M
Assets, Current 504.04M 551.09M 659.63M 867.39M 957.51M 660.38M
Assets 823.28M 916.31M 1.00B 1.19B 1.14B 816.05M
Long-term Debt 24.92M
Liabilities, Current 352.41M 366.15M 354.22M 535.64M 476.13M 393.01M
Long-term Debt, Excluding Current Maturities 0 18.25M
Liabilities 468.05M 487.69M 483.58M 627.88M 569.76M 518.21M
Stockholders' Equity Attributable to Parent 355.23M 428.62M 518.66M 560.51M 569.04M 297.84M
Common Stock, Shares, Outstanding 120.09M 121.76M 125.11M 126.67M 126.99M 112.34M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 136.87M 189.91M 100.41M -28.26M 253.23M 161.99M
Payments to Acquire Property, Plant, and Equipment 50.29M 46.22M 45.53M 33.03M
Net Cash Provided by (Used in) Investing Activities -29.52M -105.24M -50.29M -172.63M -45.53M -69.32M
Payments for Repurchase of Common Stock 80.98M 129.02M 100.06M 150.12M 50.01M 50.02M
Net Cash Provided by (Used in) Financing Activities -102.34M -137.31M -108.59M -150.26M 24.97M -27.09M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (SONO CIK 0001314727), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

LENZ

LENZ THERAPEUTICS, INC.

STRW

Strawberry Fields REIT, Inc.

CGEM

CULLINAN THERAPEUTICS, INC.